Moderna said it expects to have the vaccine, called mNEXSPIKE, available for the 2025-2026 respiratory virus season. "The FDA ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...